title: Characterization of genomic variants in CSH1 and GH2, two candidate genes for Silver-Russell syndrome in 17q24-q25.
abstract: Silver-Russell syndrome (SRS) is a syndrome of severe pre- and postnatal growth retardation and typical dysmorphic features. Rare chromosomal aberrations have been reported in SRS; among these are two balanced translocations involving 17q24-q25. Recently, we described a patient with a paternally inherited heterozygous deletion of the chorionic somatomammotropin hormone 1 (CSH1) gene. The CSH1 gene is member of the growth hormone (GH) gene cluster on 17q, which consists of two growth hormone genes and three CSH genes. Genomic alterations in the GH cluster are well known, causing different phenotypes depending on the size of the deletion and the genes involved. By screening 63 SRS cases with marker D17S254, we have detected 2 further patients with a heterozygous deletion in the GH cluster. Quantitative analysis using restriction assays confirmed these findings. Additionally, in a cohort of 17 patients with isolated intrauterine and postnatal growth retardation, we detected a further patient to be carrier of a CSH1 deletion. Screening of 141 unrelated controls revealed hemizygosity in one person for which data on growth were not available. We additionally analyzed our cohort of SRS patients for mutations in CSH1 and its 3' neighbour GH2. However, analyses failed to reveal any pathogenic mutation. While the central role of GH1 in human growth is well established, the physiological roles of CSH1 and other components of the cluster are unclear. The increased prevalence of hemizygosity of CSH1 in our population in comparison to controls indicates a role for CSH1 haploinsufficiency in the etiology of growth retardation. Investigation of CSH1 deletions in further SRS and growth retarded patients will enable us to establish under which circumstances haploinsufficiency of CSH1 is likely to result in clinical changes.
authors.affiliation: Institute of Human Genetics, RWTH Aachen, Pauwelsstrasse 30, D-52074 Aachen, Germany.
authors.forename: Sebastian
authors.initials: S
authors.lastname: Prager
authors.forename: Hartmut A
authors.initials: HA
authors.lastname: Wollmann
authors.forename: Susanne
authors.initials: S
authors.lastname: Mergenthaler
authors.forename: Miriam
authors.initials: M
authors.lastname: Mavany
authors.forename: Katja
authors.initials: K
authors.lastname: Eggermann
authors.forename: Michael B
authors.initials: MB
authors.lastname: Ranke
authors.forename: Thomas
authors.initials: T
authors.lastname: Eggermann
mesh_terms: D000015:Abnormalities, Multiple / Q000235:genetics*; D016022:Case-Control Studies; D002886:Chromosomes, Human, Pair 17; D019465:Craniofacial Abnormalities / Q000235:genetics; D005091:Exons; D005260:Female; D005317:Fetal Growth Retardation / Q000235:genetics*; D014644:Genetic Variation; D006130:Growth Disorders / Q000235:genetics; D006720:Homozygote; D019382:Human Growth Hormone / Q000235:genetics*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007438:Introns; D008297:Male; D009154:Mutation; D010928:Placental Lactogen / Q000235:genetics*; D011110:Polymorphism, Genetic; D011247:Pregnancy; D015203:Reproducibility of Results; D013577:Syndrome
chemical_list: D019382:Human Growth Hormone; D010928:Placental Lactogen